Skip to main content
    F

    Fortress Biotech Inc Pref Series A (FBIOP)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $16.75
    +0.27 (+1.64%)

    Market Cap: $77.81M

    Last updated: Oct 16, 2026 at 1:55 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    73%(11/15)
    Avg Surprise
    +13.59%
    Streak
    9 Q

    Upcoming Estimates

    Period ending Jun 30, 2026
    EPS Consensus$N/A
    Revenue Consensus
    $18M
    Range$18M - $18M
    1 analysts
    Period ending Sep 30, 2026
    EPS Consensus$N/A
    Revenue Consensus
    $22M
    Range$22M - $22M
    1 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Sep 26EST
    		-N/A---
    Jun 26EST
    		-N/A---
    Sep 25
    Reported Nov 14
    		$0.11$0.00N/ABeat+143.1%
    Jun 25
    Reported Aug 14
    		$0.45$0.00N/ABeat+1129.7%
    Mar 25
    Reported May 13
    		$-0.48$0.00N/AMiss-340.0%
    Dec 24
    Reported Mar 31
    		$-0.37$0.00N/AMiss-458.1%
    Jun 21
    Reported Aug 16
    		$-0.26$0.00N/AMiss-34.5%
    Mar 21
    Reported May 17
    		$-0.04$0.00N/AMiss+77.0%
    Dec 20
    Reported Mar 31
    		$-0.11$0.00N/AMiss+59.6%
    Sep 20
    Reported Nov 9
    		$-0.07$0.00N/AMiss+69.9%
    Jun 20
    Reported Aug 10
    		$-0.19$-0.27+29.63%Beat+20.8%
    Mar 20
    Reported May 11
    		$-0.19$-0.23+17.39%Beat-1050.0%
    Dec 19
    Reported Mar 16
    		$-0.27$-0.31+12.90%Beat+53.4%
    Sep 19
    Reported Nov 12
    		$-0.22$-0.30+26.67%Beat+40.5%
    Jun 19
    Reported Aug 9
    		$-0.24$-0.46+47.83%Beat+52.0%
    Mar 19
    Reported May 10
    		$0.02N/A+103.45%Beat+104.1%
    Dec 18
    Reported Mar 18
    		$-0.58$-0.58+0.00%Beat-163.6%
    Sep 18
    Reported Nov 9
    		$-0.37$-0.55+32.73%Beat+44.8%
    Jun 18
    Reported Aug 9
    		$-0.50$-0.59+15.25%Beat-16.3%
    Mar 18
    Reported May 10
    		$-0.49$-0.43-13.95%Miss-63.3%
    Dec 17
    Reported Mar 16
    		$-0.22N/A+65.08%Beat+50.0%
    Sep 17
    Reported Nov 9
    		$-0.67$-0.42-59.52%Miss-
    Jun 17
    Reported Aug 9
    		$-0.43$-0.29-48.28%Miss-
    Mar 17
    Reported May 10
    		$-0.30$-0.36+16.67%Beat-
    Dec 16
    Reported Mar 16
    		$-0.44$-0.31-41.94%Miss-

    Dividends

    Dividend Metrics

    Forward Yield0.00%
    Forward Annual Dividend$0.00
    Payout Ratio0.00%
    FrequencyMonthly

    Key Metrics

    Valuation
    P/E RatioN/AEV/EBITDA2.90x
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit Margin163.30%Operating Margin-53.50%
    ROE116.00%ROIC73.56%
    Financial Health
    Debt/Equity0.24xInterest Coverage17.26x
    Current Ratio3.96xQuick Ratio3.83x
    Trading Statistics
    Beta1.25Avg Volume15.36K
    52-Week High$21.4352-Week Low$6.27

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$17.55
    SMA 20$17.20
    SMA 50$18.07
    SMA 200$15.94
    EMA 10$17.25
    EMA 20$17.41
    EMA 50$17.82
    EMA 200$15.82

    MACD

    Line: -0.23Signal: -0.23Hist: -0.00

    ADX

    ADX: 26.2+DI: 16.7-DI: 29.3

    Aroon & PSAR

    Aroon Up4.0
    Aroon Down52.0
    PSAR$18.54

    Bollinger Bands

    Upper Band$18.54
    Lower Band$15.85
    %B Position1563%(Upper)
    Band Width0.33

    RSI (14-Day)

    Neutral
    40.9

    Momentum Oscillators

    Stoch %K33.1
    Stoch %D46.9
    Williams %R-72.0
    ROC (10d)4.3%
    Momentum0.69
    CCI (20d)-66.4
    MFI (14d)31.7

    Volatility Measures

    ATR (14d)$0.62(3.7%)
    StdDev (20d)0.67
    Hist Vol44.8%(High)

    Volume Flow

    VWAP$16.64
    OBV782.5K
    AD Line1.3M
    CMF (20d)0.135

    Volume Metrics

    Avg Vol (20d)15.4K
    Vol Ratio0.8x
    VWMA (20d)$16.95

    Pivot Points

    R3$17.68
    R2$17.39
    R1$16.94
    Pivot Point$16.65
    S1$16.20
    S2$15.91
    S3$15.46

    Advanced Oscillators

    TSI-11.54
    Ultimate Osc50.7
    KST-39.59

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$18.72M$16.04M$16.08M$17.63M$16.41M$13.14M$15.12M$14.63M$14.90M$13.03M$19.95M$34.75M
    Cost of Revenue$7.11M$7.34M$5.44M$5.75M$4.94M$4.79M$5.80M$5.29M$6.54M$6.00M$6.01M$6.43M
    Gross Profit$11.61M$8.69M$10.64M$11.88M$11.47M$8.35M$9.31M$9.34M$8.36M$7.03M$13.93M$28.32M
    Operating Expenses$21.61M$16.43M$15.43M$18.69M$47.95M$30.67M$36.66M$31.44M$36.14M$43.59M$33.55M$42.08M
    R&D$805,000$540,000$367,000$208,000$8.13M$3.94M$9.94M$9.45M$12.67M$24.84M$14.08M$20.35M
    SG&A$20.81M$15.89M$14.73M$17.41M$38.76M$25.66M$26.86M$21.99M$20.82M$17.94M$22.61M$21.73M
    Operating Income$-10,005,000$-7,739,000$-4,789,000$-6,811,000$-36,473,000$-22,317,000$-27,345,000$-22,095,000$-27,788,000$-36,566,000$-19,614,000$-13,758,000
    Interest Income$1.58M$570,000$637,000$736,000$622,000$490,000$526,000$589,000$734,000$833,000$707,000$547,000
    Interest Expense$1.48M$3.37M$1.71M$2.42M$2.07M$2.51M$2.59M$6.21M$2.12M$2.60M$2.06M$2.53M
    Income Before Tax$900,000$142.29M$-6,213,000$8.85M$-11,654,000$-24,691,000$-25,979,000$-26,625,000$-28,824,000$-39,023,000$-28,605,000$-10,583,000
    Income Tax Expense$298,000$5.13M$-816,000$26,000$0$0$336,000$69,000$-2,565,000$-1,719,000$379,000$141,000
    Net Income$-468,000$110.37M$-3,937,000$5.85M$15.49M$-10,584,000$-6,765,000$-12,867,000$-10,948,000$-15,417,000$-9,279,000$-5,045,000
    EBITDA$3.44M$147.36M$-3,347,000$12.43M$-8,424,000$-20,505,000$-21,780,000$-21,066,000$-26,142,000$-35,839,000$-25,381,000$-5,954,000
    EBIT$2.38M$145.66M$-4,504,000$11.27M$-9,580,000$-22,181,000$-23,385,000$-24,389,000$-27,333,000$-37,030,000$-27,090,000$-8,706,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about FBIOP

    News

    Fortress Biotech repays USD 15 million debt: what it means for Fortress Biotech stock

    Fortress Biotech (FBIO) repaid $15 million of Oaktree principal on September 30, 2026, ending its senior secured credit agreement. This repayment follows a $130 million Series B financing for Crystalys Therapeutics...

    ad-hoc-news.de•10/14/26•Neutral

    Fortress Biotech repays USD 15 million debt: what it means for Fortress Biotech stock

    Fortress Biotech has repaid $15 million of Oaktree principal, removing related liens and ending a senior secured credit agreement. This move follows a $130 million Series B financing for Crystalys Therapeutics...

    ad-hoc-news.de•10/14/26•Neutral

    Fortress Biotech stock fell 1.93 percent on October 2

    Fortress Biotech (FBIO) stock dropped 1.93% on October 2, 2026, closing at USD 2.03. This occurred after the company announced a USD 15.0 million repayment on its Oaktree credit facility...

    AD HOC NEWS•10/4/26•Neutral

    Form 8K Fortress Biotech Inc For: 1 October By Investing.com

    Investing.com published an article announcing Fortress Biotech Inc.'s Form 8K filing for October 1st. The brief article, including the stock symbol FBIO, focuses solely on this regulatory news.

    Investing.com Canada•10/2/26•Neutral

    Fortress Biotech repays $15 million Oaktree credit facility in full By Investing.com

    Fortress Biotech has fully repaid its $15 million senior secured credit facility with Oaktree Fund Administration, LLC, including accrued interest, a prepayment fee, and closing costs. This repayment...

    Investing.com Nigeria•10/2/26•Bullish

    FBIOP Valuation and Fair Value

    EV/EBITDA
    2.9x
    P/B
    3.8x
    See GNG's fair value

    FBIOP Profitability: Margins, ROIC and FCF

    Gross margin
    62.5%
    Operating margin
    -53.5%
    Net margin
    163.3%
    ROIC
    73.6%
    ROE
    116.0%
    FCF margin
    183.8%

    FBIOP Competitors

    CompanyTicker
    LifeMD Inc Preferred Series ALFMDP
    Star Equity Holdings PrfSTRRP

    Sector: Healthcare

    FBIOP Bull Case vs Bear Case

    Bull case

    • FBIOP earns a 73.6% return on invested capital.
    • FBIOP converts 183.8% of revenue into free cash flow.
    • FBIOP has a 163.3% net profit margin.

    Bear case

    • FBIOP beat EPS estimates in 25.0% of its last 8 reported quarters.

    FBIOP Earnings: Beat Rate and Next Report

    Beat rate
    2 of 8 quarters (25.0%)

    FBIOP Dividend

    Forward yield
    0.0%
    Payout ratio
    0.0%

    Frequently Asked Questions About FBIOP

    Does FBIOP pay dividends?

    Fortress Biotech Inc Pref Series A (FBIOP) has a dividend payment track record. See the FBIOP dividend history page for its current payment status, TTM yield, and recorded payments.

    What is FBIOP's market cap?

    Fortress Biotech Inc Pref Series A (FBIOP) has a market capitalization of $77.81M with a current stock price of $16.75.

    Related stocks

    Sector: Healthcare

    All stocks starting with F

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In